Fifth Third Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.21M Buy
33,341
+286
+0.9% +$37.7K 0.12% 128
2026
Q1
$4.61M Buy
33,055
+16,196
+96% +$2.27M 0.16% 107
2025
Q4
$2.07M Buy
16,859
+3,324
+25% +$404K 0.07% 170
2025
Q3
$1.5M Buy
13,535
+772
+6% +$87.7K 0.06% 197
2025
Q2
$1.42M Sell
12,763
-536
-4% -$57K 0.06% 202
2025
Q1
$1.49M Buy
13,299
+1,505
+13% +$155K 0.08% 171
2024
Q4
$1.09M Sell
11,794
-1,068
-8% -$96.2K 0.06% 194
2024
Q3
$1.08M Buy
12,862
+1,364
+12% +$104K 0.07% 184
2024
Q2
$789K Buy
11,498
+3,647
+46% +$243K 0.06% 190
2024
Q1
$575K Buy
7,851
+2,945
+60% +$226K 0.09% 144
2023
Q4
$397K Sell
4,906
-30
-0.6% -$2.33K 0.13% 128
2023
Q3
$370K Buy
+4,936
New +$380K 0.15% 127

Other funds holding GILD

Fifth Third Wealth Advisors's GILD Position: Q2 2026 in Review

Fifth Third Wealth Advisors increased its Gilead Sciences (GILD) stake by 0.87% in Q2 2026, buying an estimated $37.7K and bringing the position to 33,341 shares worth $4.21M. The position accounts for 0.12% of the portfolio, ranked #128.

Fifth Third Wealth Advisors first reported a position in GILD in Q3 2023 and has held it in 12 quarters since. The position peaked at $4.61M in Q1 2026. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Fifth Third Wealth Advisors held 33,341 shares of Gilead Sciences worth $4.21M as of Q2 2026.
  • Fifth Third Wealth Advisors bought 286 Gilead Sciences shares in Q2 2026, an estimated $37.7K.
  • Gilead Sciences made up 0.12% of Fifth Third Wealth Advisors's portfolio in Q2 2026, its #128 holding.
  • Fifth Third Wealth Advisors first reported a position in Gilead Sciences in Q3 2023 and has held it in 12 quarters since.
  • Fifth Third Wealth Advisors's Gilead Sciences position peaked at $4.61M in Q1 2026.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.